BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10408161)

  • 1. Usefulness of the zung self-rating depression scale for schizophrenics.
    Kaneda Y
    J Med Invest; 1999 Feb; 46(1-2):75-8. PubMed ID: 10408161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psychometric properties of French version of the Calgary depression scale for schizophrenics (CDSS)].
    Reine G; Bernard D; Auquier P; Le Fur B; Lançon C
    Encephale; 2000; 26(1):52-61. PubMed ID: 10875062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Calgary Depression Rating Scale for schizophrenia in a healthy control group: psychometric properties and reference values.
    Müller MJ; Brening H; Gensch C; Klinga J; Kienzle B; Müller KM
    J Affect Disord; 2005 Sep; 88(1):69-74. PubMed ID: 16040126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity of a Brazilian version of the Zung self-rating depression scale for screening of depression in patients with Parkinson's disease.
    Chagas MH; Tumas V; Loureiro SR; Hallak JE; Trzesniak C; de Sousa JP; Rodrigues GG; Santos Filho A; Crippa JA
    Parkinsonism Relat Disord; 2010 Jan; 16(1):42-5. PubMed ID: 19660977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Self-rating scales in schizophrenia: assessment of the reliability of the Paranoid-Depressive Scale (PD-S) Frankfurt Self-feeling Scale (FBS). and two visual analogy scales].
    Schaeffer E; Wciórka J
    Psychiatr Pol; 2003; 37(1):121-33. PubMed ID: 12685309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Validity and reliability of the Turkish version of the Wender Utah Rating Scale for attention-deficit/hyperactivity disorder in adults].
    Oncü B; Olmez S; Sentürk V
    Turk Psikiyatri Derg; 2005; 16(4):252-9. PubMed ID: 16362844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the Zung Self-Rating Depression Scale in cancer patients: feasibility as a screening tool.
    Dugan W; McDonald MV; Passik SD; Rosenfeld BD; Theobald D; Edgerton S
    Psychooncology; 1998; 7(6):483-93. PubMed ID: 9885089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of the Affective Self Rating Scale for manic, depressive, and mixed affective states.
    Adler M; Liberg B; Andersson S; Isacsson G; Hetta J
    Nord J Psychiatry; 2008; 62(2):130-5. PubMed ID: 18569776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Translation and validation of a French version of the Young Mania Rating Scale (YMRS)].
    Favre S; Aubry JM; Gex-Fabry M; Ragama-Pardos E; McQuillan A; Bertschy G
    Encephale; 2003; 29(6):499-505. PubMed ID: 15029084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of depression using the Zung Self-Rating Depression Scale.
    Colón de Martí LN; Guzmán Yunqué FS; Guevara-Ramos LM
    P R Health Sci J; 1997 Dec; 16(4):375-9. PubMed ID: 9547828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptation and validation of the Spanish version of the Mood Disorder Questionnaire for the detection of bipolar disorder.
    Sanchez-Moreno J; Villagran JM; Gutierrez JR; Camacho M; Ocio S; Palao D; Querejeta I; Gascon J; Sanchez G; Vieta E;
    Bipolar Disord; 2008 May; 10(3):400-12. PubMed ID: 18402628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of a depression score to predict candidacy for hepatitis C virus therapy in veterans: a prospective longitudinal study.
    Tavakoli-Tabasi S; Rowan P; Abdul-Latif M; Kunik ME; El-Serag HB
    Aliment Pharmacol Ther; 2005 Feb; 21(3):235-42. PubMed ID: 15691297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anhedonia in schizophrenia].
    Loas G; Boyer P; Legrand A; Gayant C; Delahousse J
    Encephale; 1995; 21(6):453-7. PubMed ID: 8674470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Scharfetter's EPP (Ego-Psychopathology) questionnaire in Polish setting].
    Tyczyński K; Wciórka J
    Psychiatr Pol; 2003; 37(2):269-80. PubMed ID: 12776658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reliability and validity of the Oppositional Defiant Behavior Inventory.
    Harada Y; Saitoh K; Iida J; Sakuma A; Iwasaka H; Imai J; Hirabayashi M; Yamada S; Hirabayashi S; Uchiyama T; Ohta S; Amano N
    Eur Child Adolesc Psychiatry; 2004 Jun; 13(3):185-90. PubMed ID: 15254847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the Retardation Rating Scale for detecting depression in geriatric inpatients.
    Bonin-Guillaume S; Sautel L; Demattei C; Jouve E; Blin O
    Int J Geriatr Psychiatry; 2007 Jan; 22(1):68-76. PubMed ID: 16988949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurological soft signs in schizophrenic patients and their nonaffected siblings].
    Mechri A; Slama H; Bourdel MC; Chebel S; Mandhouj O; Krebs MO; Gaha L
    Encephale; 2008 Oct; 34(5):483-9. PubMed ID: 19068337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing depression in schizophrenia: the Calgary Depression Scale.
    Addington D; Addington J; Maticka-Tyndale E
    Br J Psychiatry Suppl; 1993 Dec; (22):39-44. PubMed ID: 8110442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of Post-traumatic Stress Disorder: validation of a measure, the PCLS].
    Yao SN; Cottraux J; Note I; De Mey-Guillard C; Mollard E; Ventureyra V
    Encephale; 2003; 29(3 Pt 1):232-8. PubMed ID: 12876547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new rating scale for negative symptoms: the Motor-Affective-Social Scale.
    Trémeau F; Goggin M; Antonius D; Czobor P; Hill V; Citrome L
    Psychiatry Res; 2008 Sep; 160(3):346-55. PubMed ID: 18722021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.